Immunic, Inc. Announces Private Placement of up to $240 Million

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

Related Keywords

Ukraine ,United States ,Russia ,Edna Kaplan ,Piper Sandler ,Paula Schwartz ,Jessica Breu ,Ladenburg Thalmann ,Prnewswire Immunic Inc ,Arcadia Securities ,Immunic Inc ,Nasdaq ,Rx Communications Group ,Exchange Commission ,Avidity Partners ,Janus Henderson Investors ,Soleus Capital ,Adage Capital Partners ,Brookline Capital Markets ,Securities Act ,Private Securities Litigation Reform Act ,Middle East ,Annual Report ,Investor Relations ,Markets ,